Atossa Therapeutics
ATOS
#9315
Rank
NZ$0.16 B
Marketcap
NZ$1.27
Share price
3.82%
Change (1 day)
-27.09%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$86.46 Million

According to Atossa Therapeutics's latest financial reports the company has NZ$86.46 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.12 B-11.94%
2023-12-31$NZ$0.14 B-22.54%
2022-12-31$NZ$0.18 B-8.13%
2021-12-31$NZ$0.20 B437.11%
2020-12-31$NZ$37.65 M92.75%
2019-12-31$NZ$19.53 M48.81%
2018-12-31$NZ$13.12 M34.36%
2017-12-31$NZ$9.77 M118.51%
2016-12-31$NZ$4.47 M-18.22%
2015-12-31$NZ$5.46 M-54.9%
2014-12-31$NZ$12.12 M-6.04%
2013-12-31$NZ$12.9 M105.06%
2012-12-31$NZ$6.29 M214.81%
2011-12-31$NZ$1.99 M-280.99%
2010-12-31$-NZ$1.11 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$137.68 B 159,132.33%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$15.13 B 17,400.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$12.80 B 14,715.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$75.36 M-12.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$1.45 B 1,583.75%๐Ÿ‡บ๐Ÿ‡ธ USA